Bottom line
JDOC vs SHSSX: the short answer
JDOC (JPMorgan Healthcare Leaders ETF) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) share a meaningful slice of their top holdings — about 55% by weight.
But SHSSX is far broader, holding 155 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
JDOC is cheaper at 0.65% vs 0.86% — a difference of $21 a year per $10,000 invested.
Over one year, SHSSX returned +16.3% vs +14.9% for JDOC.
Updated Nov 19, 2026
JDOC vs SHSSX side by side
| JDOC | SHSSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | J.P. Morgan | BlackRock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.65% | 0.86% |
| Annual cost per $10k | $65 | $86 |
| 10-yr cost on $10k (prospectus) | $810 | $1,061 |
| Max front load | None | 0% |
| 12b-1 fee | — | 0% |
| 1-yr return | +14.9% | +16.3% |
| 5-yr return (annualized) | — | +5.9% |
| 10-yr return (annualized) | — | +9.8% |
| Best quarter | +11.3% | — |
| Worst quarter | −11.9% | — |
| Net assets (fund) | $9.1M | $5.9B |
| Number of holdings | 61 | 155 |
| Portfolio turnover | 92% | 49% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of JDOC's top 25 holdings also appear in SHSSX's top 25.
| Holding | JDOC | SHSSX |
|---|---|---|
| AbbVie, Inc. | 7.85% | 3.94% |
| Eli Lilly & Co. | 7.76% | 12.29% |
| UnitedHealth Group, Inc. | 5.85% | 6.10% |
| Merck & Co., Inc. | 4.82% | 4.94% |
| Johnson & Johnson | 4.82% | 8.77% |
| AstraZeneca plc | 3.76% | 1.21% |
| Thermo Fisher Scientific, Inc. | 3.73% | 3.02% |
| Abbott Laboratories | 3.11% | 1.97% |
| Stryker Corp. | 2.23% | 1.15% |
| Danaher Corp. | 2.16% | 2.00% |
| Intuitive Surgical, Inc. | 1.93% | 1.95% |
| Edwards Lifesciences Corp. | 1.73% | 2.51% |
| Regeneron Pharmaceuticals, Inc. | 1.60% | 0.91% |
| Biogen, Inc. | 1.56% | 1.21% |
Source: SEC Form N-PORT
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
FAQ
What is the difference between JDOC and SHSSX?
Which is cheaper, JDOC or SHSSX?
Should I own both JDOC and SHSSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.